These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
9. Interferon-gamma in a family with X-linked lymphoproliferative syndrome with acute Epstein-Barr virus infection. Okano M; Thiele GM; Kobayashi RH; Davis JR; Synovec MS; Grierson HL; Jaffe HS; Purtilo DT J Clin Immunol; 1989 Jan; 9(1):48-54. PubMed ID: 2539385 [TBL] [Abstract][Full Text] [Related]
10. X-linked lymphoproliferative syndrome. Natural history of the immunodeficiency. Sullivan JL; Byron KS; Brewster FE; Baker SM; Ochs HD J Clin Invest; 1983 Jun; 71(6):1765-78. PubMed ID: 6306053 [TBL] [Abstract][Full Text] [Related]
11. Epstein-Barr virus-infected B cells of males with the X-linked lymphoproliferative syndrome stimulate and are susceptible to T-cell-mediated lysis. Jäger M; Benninger-Döring G; Prang N; Sylla BS; Laumbacher B; Wank R; Wolf H; Schwarzmann F Int J Cancer; 1998 May; 76(5):694-701. PubMed ID: 9610728 [TBL] [Abstract][Full Text] [Related]
12. Prevention and treatment of Epstein-Barr virus (EBV)-associated lymphoproliferative diseases in immune deficient patients. Purtilo DT AIDS Res; 1986 Dec; 2 Suppl 1():S177-81. PubMed ID: 2435295 [TBL] [Abstract][Full Text] [Related]
13. NTB-A [correction of GNTB-A], a novel SH2D1A-associated surface molecule contributing to the inability of natural killer cells to kill Epstein-Barr virus-infected B cells in X-linked lymphoproliferative disease. Bottino C; Falco M; Parolini S; Marcenaro E; Augugliaro R; Sivori S; Landi E; Biassoni R; Notarangelo LD; Moretta L; Moretta A J Exp Med; 2001 Aug; 194(3):235-46. PubMed ID: 11489943 [TBL] [Abstract][Full Text] [Related]
15. Immunoregulatory T cells in males vulnerable to Epstein-Barr virus with the X-linked lymphoproliferative syndrome. Lai PK; Yasuda N; Purtilo DT Am J Pediatr Hematol Oncol; 1987; 9(2):179-82. PubMed ID: 3035958 [TBL] [Abstract][Full Text] [Related]